便蛋白质质谱法识别了用于早期检测扩散型胃癌的生物标志物
Chi-Lee C Ho1,2, Michael B Gilbert3, Guillaume Urtecho4
1Department of Surgery, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
Cancer prevention research (Philadelphia, Pa.)
|April 26, 2024
概括
研究人员确定了新的便蛋白生物标志物,用于早期检测扩散性胃癌 (DGC). 在便样本中分析这些生物标志物显示出改善临床结果和预防晚期疾病的前景.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 生物标志物发现发现
背景情况:
- 由于缺乏有效的早期检测方法,扩散性胃癌 (DGC) 构成了重大挑战.
- 早期诊断对于改善胃癌患者的预后和治疗结果至关重要.
研究的目的:
- 调查便蛋白质组作为潜在的生物标志物的实用性,用于早期检测DGC.
- 在小鼠模型和遗传性扩散性胃癌 (HDGC) 患者中识别便中与胃癌相关的特定蛋白质签名.
主要方法:
- 蛋白质质质谱法用于从基因工程小鼠模型 (TCON小鼠) 和患有HDGC的患者的便样本.
- 免疫块检测和免疫光被用来验证蛋白质的丰富性和表达.
- 进行了化学抑制试验,以评估已识别的蛋白质在癌细胞中的功能作用.
主要成果:
- 蛋白质组分析显示,与对照组相比,TCON小鼠和HDGC患者的便中富含了特定蛋白质 (例如ACTN4,ASAH2,DPP4,VCP).
- 在TCON小鼠的胃组织中也观察到这些蛋白质的表达增加.
- 抑制ASAH2对胃癌细胞表现出毒性,这表明它是一个潜在的治疗点.
结论:
- 这项研究提供了便蛋白生物标志物的潜力在早期检测DGC的证据.
- 这些发现突出了一个新的生物标志物小组,可以帮助早期诊断和改善胃癌的临床管理.
- 对便蛋白质组分析的进一步研究可能会导致DGC的非侵入性诊断工具.
相关概念视频
Serum Laboratory Studies, Stool Test, Breath Test
342
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
342
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
115
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
115
MALDI-TOF Mass Spectrometry
4.8K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
4.8K


